PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.49%
Revenue growth under 50% of ADI's 6.02%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
6.95%
Gross profit growth at 75-90% of ADI's 8.09%. Bill Ackman would demand operational improvements to match competitor gains.
39.71%
EBIT growth above 1.5x ADI's 17.92%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
39.71%
Operating income growth above 1.5x ADI's 17.92%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
37.31%
Net income growth above 1.5x ADI's 16.99%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
33.33%
EPS growth above 1.5x ADI's 20.00%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
33.33%
Diluted EPS growth above 1.5x ADI's 20.00%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.82%
Share count expansion well above ADI's 0.81%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.55%
Diluted share count expanding well above ADI's 0.81%. Michael Burry would fear significant dilution to existing owners' stakes.
-0.81%
Dividend reduction while ADI stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-29.54%
Negative OCF growth while ADI is at 152.58%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-82.21%
Negative FCF growth while ADI is at 228.32%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
65.84%
10Y revenue/share CAGR at 50-75% of ADI's 91.84%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
35.07%
5Y revenue/share CAGR similar to ADI's 38.24%. Walter Schloss might see both companies benefiting from the same mid-term trends.
26.89%
Positive 3Y CAGR while ADI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1140.12%
3Y OCF/share CAGR above 1.5x ADI's 74.69%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
1129.69%
10Y net income/share CAGR of 1129.69% while ADI is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
52.11%
5Y net income/share CAGR 1.25-1.5x ADI's 45.30%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
199.89%
3Y net income/share CAGR above 1.5x ADI's 93.74%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
16.43%
Positive short-term equity growth while ADI is negative. John Neff sees a strong advantage in near-term net worth buildup.
10.94%
Dividend/share CAGR of 10.94% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
2.72%
Dividend/share CAGR of 2.72% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
-88.41%
Negative near-term dividend growth while ADI invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
7.11%
AR growth well above ADI's 7.35%. Michael Burry fears inflated revenue or higher default risk in the near future.
4.86%
We show growth while ADI is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
3.78%
Asset growth at 50-75% of ADI's 6.76%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
6.90%
BV/share growth above 1.5x ADI's 3.53%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-1.41%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-8.17%
We cut SG&A while ADI invests at 2.93%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.